These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
374 related items for PubMed ID: 18005174
1. Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study. Abdou AG, Hanout HM. J Cutan Pathol; 2008 May; 35(5):445-51. PubMed ID: 18005174 [Abstract] [Full Text] [Related]
2. Nature of cell kinetics in psoriatic epidermis. Doger FK, Dikicioglu E, Ergin F, Unal E, Sendur N, Uslu M. J Cutan Pathol; 2007 Mar; 34(3):257-63. PubMed ID: 17302610 [Abstract] [Full Text] [Related]
3. Downregulation of the inhibitor of apoptosis protein survivin in keratinocytes and endothelial cells in psoriasis skin following infliximab therapy. Markham T, Mathews C, Rogers S, Mullan R, Bresnihan B, Fitzgerald O, Veale DJ, Fearon U. Br J Dermatol; 2006 Dec; 155(6):1191-6. PubMed ID: 17107388 [Abstract] [Full Text] [Related]
4. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas. Angileri FF, Aguennouz M, Conti A, La Torre D, Cardali S, Crupi R, Tomasello C, Germanò A, Vita G, Tomasello F. Cancer; 2008 May 15; 112(10):2258-66. PubMed ID: 18327814 [Abstract] [Full Text] [Related]
5. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively. Tracey L, Pérez-Rosado A, Artiga MJ, Camacho FI, Rodríguez A, Martínez N, Ruiz-Ballesteros E, Mollejo M, Martinez B, Cuadros M, Garcia JF, Lawler M, Piris MA. J Pathol; 2005 Jun 15; 206(2):123-34. PubMed ID: 15880597 [Abstract] [Full Text] [Related]
6. NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues. Meteoglu I, Erdogdu IH, Meydan N, Erkus M, Barutca S. J Exp Clin Cancer Res; 2008 Oct 19; 27(1):53. PubMed ID: 18928570 [Abstract] [Full Text] [Related]
7. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study. Simonetti O, Lucarini G, Bernardini ML, Simoncini C, Biagini G, Offidani A. Br J Dermatol; 2004 May 19; 150(5):940-8. PubMed ID: 15149507 [Abstract] [Full Text] [Related]
8. Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept. Lizzul PF, Aphale A, Malaviya R, Sun Y, Masud S, Dombrovskiy V, Gottlieb AB. J Invest Dermatol; 2005 Jun 19; 124(6):1275-83. PubMed ID: 15955104 [Abstract] [Full Text] [Related]
9. K16 expression in uninvolved psoriatic skin: a possible marker of pre-clinical psoriasis. Bhawan J, Bansal C, Whren K, Schwertschlag U, IL-11 Psoriasis Study Group. J Cutan Pathol; 2004 Aug 19; 31(7):471-6. PubMed ID: 15239676 [Abstract] [Full Text] [Related]
10. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers. Seo SI, Song SY, Kang MR, Kim MS, Oh JE, Kim YR, Lee JY, Yoo NJ, Lee SH. APMIS; 2009 Aug 19; 117(8):623-8. PubMed ID: 19664134 [Abstract] [Full Text] [Related]
11. Expression of antiapoptotic protein c-FLIP is upregulated in psoriasis epidermis. Yang J, Li Y, Liu YQ, Long JW, Tian F, Dong J, Shen GX, Tu YT, Tao J. Eur J Dermatol; 2009 Aug 19; 19(1):29-33. PubMed ID: 19059832 [Abstract] [Full Text] [Related]
12. Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma. Piras F, Murtas D, Minerba L, Ugalde J, Floris C, Maxia C, Colombari R, Perra MT, Sirigu P. Histopathology; 2007 Jun 19; 50(7):835-42. PubMed ID: 17543072 [Abstract] [Full Text] [Related]
13. Tight junction components occludin, ZO-1, and claudin-1, -4 and -5 in active and healing psoriasis. Peltonen S, Riehokainen J, Pummi K, Peltonen J. Br J Dermatol; 2007 Mar 19; 156(3):466-72. PubMed ID: 17300235 [Abstract] [Full Text] [Related]
14. Perforin expression is upregulated in the epidermis of psoriatic lesions. Kastelan M, Prpić Massari L, Gruber F, Zamolo G, Zauhar G, Coklo M, Rukavina D. Br J Dermatol; 2004 Oct 19; 151(4):831-6. PubMed ID: 15491424 [Abstract] [Full Text] [Related]
15. Infliximab restores the balance between pro- and anti-apoptotic proteins in regressing psoriatic lesions. Kokolakis G, Giannikaki E, Stathopoulos E, Avramidis G, Tosca AD, Krüger-Krasagakis S. Br J Dermatol; 2012 Mar 19; 166(3):491-7. PubMed ID: 21985184 [Abstract] [Full Text] [Related]
16. Targeting NF-kappa B with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasis. Wang H, Syrovets T, Kess D, Büchele B, Hainzl H, Lunov O, Weiss JM, Scharffetter-Kochanek K, Simmet T. J Immunol; 2009 Oct 01; 183(7):4755-63. PubMed ID: 19752240 [Abstract] [Full Text] [Related]
17. Role of NF-κB in the pathogenesis of psoriasis elucidated by its staining in skin biopsy specimens. Moorchung N, Kulaar JS, Chatterjee M, Vasudevan B, Tripathi T, Dutta V. Int J Dermatol; 2014 May 01; 53(5):570-4. PubMed ID: 23621342 [Abstract] [Full Text] [Related]
18. Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling. Ng SB, Selvarajan V, Huang G, Zhou J, Feldman AL, Law M, Kwong YL, Shimizu N, Kagami Y, Aozasa K, Salto-Tellez M, Chng WJ. J Pathol; 2011 Mar 01; 223(4):496-510. PubMed ID: 21294123 [Abstract] [Full Text] [Related]
19. NF-κB: an essential transcription factor in psoriasis. Goldminz AM, Au SC, Kim N, Gottlieb AB, Lizzul PF. J Dermatol Sci; 2013 Feb 01; 69(2):89-94. PubMed ID: 23219896 [Abstract] [Full Text] [Related]
20. Avarol inhibits TNF-alpha generation and NF-kappaB activation in human cells and in animal models. Amigó M, Payá M, Braza-Boïls A, De Rosa S, Terencio MC. Life Sci; 2008 Jan 30; 82(5-6):256-64. PubMed ID: 18177902 [Abstract] [Full Text] [Related] Page: [Next] [New Search]